Calidi Biotherapeutics (NYSE American: CLDI) , a clinical-stage biotechnology company advancing targeted immunotherapies, has entered into a securiti ...

Biotherapeutics has entered into a definitive securities purchase agreement with a single institutional investor for the purchase ...

Calidi Biotherapeutics, Inc. (NYSE AMERICAN: CLDI) (“Calidi” or the “Company”), a clinical-stage biotechnology company developing a new generation of targeted immunotherapies, today announced that it ...

Thank you for standing by and welcome to the Corvus Pharmaceuticals fourth-quarter and full-year 2024 business update and financial results conference call. (Operator Instructions) It is now my ...

Discover Corvus Pharmaceuticals' Q4 2024 earnings insights, highlighting soquelitinib's trial progress, upcoming milestones for 2025, and robust ...

("Osaic"), one of the nation's largest providers of wealth management solutions, today announced that Ever Wealth, an Auburn, Indiana-based advisory firm with more than $170 million in client assets, ...

Fintel reports that on March 19, 2025, Ladenburg Thalmann downgraded their outlook for Public Service Enterprise Group ...

Fintel reports that on March 17, 2025, Ladenburg Thalmann initiated coverage of Veritone (NasdaqGM:VERI) with a Buy ...

At the opening bell, the S&P 500 increased 27.46 points, or 0.49%, to 5,666.40 and the Nasdaq Composite rose 59.43 points, or ...

A Commerce Department report showed retail sales rebounded 0.2% in February, after a revised 1.2% decline in January. However ...

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...